In March 2025, the company announced new designs to get a direct-to-consumer offering of its Wegovy weight loss drug. The company recognized a completely new pharmacy, termed NovoCare, which might cost customers $499 each month for use of the drug, below fifty percent the expense of the drug by other pharmaceutical distribution networks.[53]Rybelsu